Absence of microglia or presence of peripherally‐derived macrophages does not affect tau pathology in young or old hTau mice
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Microglia are implicated in the pathophysiology of several neurodegenerative disorders, including Alzheimer's disease. While the role of microglia and peripheral macrophages in regulating amyloid beta pathology has been well characterized, the impact of these distinct cell subsets on tau pathology remains poorly understood. We and others have recently demonstrated that monocytes can engraft the brain and give rise to long‐lived parenchymal macrophages, even under nonpathological conditions. We undertook the current study to investigate the regulation of tau pathology by microglia and peripheral macrophages using hTau transgenic mice, which do not exhibit microglial activation/pathology or macrophage engraftment. To assess the direct impact of microglia on tau pathology we developed a protocol for long‐term microglial depletion in Cx3cr1CreERR26DTA mice and crossed them with hTau mice. We then depleted microglia up to 3 months in both young and old mice, but no net change in forebrain soluble oligomeric tau or total or phosphorylated levels of aggregated tau was recorded. To investigate the consequence of peripherally‐derived parenchymal macrophages on tau aggregation we partially repopulated the hTau microglial pool with peripheral macrophages, but this also did not affect levels of tau oligomers or insoluble aggregates. Our study questions the direct involvement of microglia or peripheral macrophages in the development of tau pathology in the hTau model.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Identification of a unique TGF-β–dependent molecular and functional signature in microglia
Butovsky, O., Jedrychowski, M. P., Moore, C. S., Cialic, R., Lanser, A. J., Gabriely, G., Koeglsperger, T., Dake, B., Wu, P. M., Doykan, C. E., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3599 · Cited by 2,543 · cited 1×
“More specifically, hTau and nontransgenic microglia expressed similar levels of the microglial homeostatic genes P2ry12, Fcrls, Siglech, Tmem119, and Sall1 (Butovsky et al., 2013; Lund, Pieber, Parsa, Han, et al., 2018; Figure 1f).”
BackgroundMicroglia and macrophages in brain homeostasis and disease
Li, Q., & Barres, B. A. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.125 · Cited by 1,999
NLRP3 inflammasome activation drives tau pathology
Ising, C., Venegas, C., Zhang, S., Scheiblich, H., Schmidt, S. V., Vieira-Saecker, A., Schwartz, S., Albasset, S., McManus, R. M., Tejera, D., et al. (2019) · Nature · doi:10.1038/s41586-019-1769-z · Cited by 1,487
Lewis, J., McGowan, E., Rockwood, J., Melrose, H., Nacharaju, P., Van Slegtenhorst, M., Gwinn-Hardy, K., Murphy, M. P., Baker, M., Yu, X., et al. (2000) · Nature Genetics · doi:10.1038/78078 · Cited by 1,371 · cited 3×
“…hTau mice in which tau pathology progresses more slowly than other commonly used tau transgenic mouse models, including JNPL3 (Acker et al., 2013; Lewis et al., 2000), PS19 (Yoshiyama et al., 2007), and rTg4510 (Ramsden et al., 2005), which all express frontotemporal dementia-associated mutant…”
BackgroundMethodApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy
Initiative, A. D. N., Shi, Y., Yamada, K., Liddelow, S. A., Smith, S. T., Zhao, L., Luo, W., Tsai, R. M., Spina, S., Grinberg, L. T., et al. (2017) · Nature · doi:10.1038/nature24016 · Cited by 1,220 · cited 1×
“Homozygous expression of human APOE4 in P301S mice results in severe brain atrophy (Shi et al., 2017) which is completely rescued by high-efficiency microglia depletion using PLX3397 (Shi et al., 2019).”
BackgroundMicroglia development and function
Nayak, D., Roth, T. L., & McGavern, D. B. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120240 · Cited by 1,154 · cited 1×
“Compared to amyloid beta plaques, neurofibrillary tangle load correlates better with the severity of brain atrophy and cognitive decline (Nelson et al., 2012), which has also been confirmed by positron emission tomography (PET) studies (Cho, Choi, Hwang, Kim, et al., 2016; Cho, Choi, Hwang, Lee, et…”
BackgroundShemer, A., Grozovski, J., Tay, T. L., Tao, J., Volaski, A., Süß, P., Ardura-Fabregat, A., Gross-Vered, M., Kim, J.-S., David, E., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07548-5 · Cited by 1,052 · cited 3×
“Using PLX3397 to achieve a 30% reduction in microglial numbers during a 3 month time-period, Bennett et al did not observe effects on tau-associated pathology in aged rTg4510 mice, including tau burden, cortical atrophy, vascularization, or astrocyte activation (Bennett, Bryant, et al., 2018).”
BackgroundMrdjen, D., Pavlovic, A., Hartmann, F. J., Schreiner, B., Utz, S. G., Leung, B. P., Lelios, I., Heppner, F. L., Kipnis, J., Merkler, D., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.01.011 · Cited by 1,010
Streit, W. J., Braak, H., Xue, Q.-S., & Bechmann, I. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0556-6 · Cited by 727 · cited 1×
“Microglial proliferation is a well characterized response to neurodegeneration (Gomez-Nicola, Fransen, Suzzi, & Perry, 2013; Tay et al., 2017).”
BackgroundHyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms
Andorfer, C., Kress, Y., Espinoza, M., De Silva, R., Tucker, K. L., Barde, Y., Duff, K., & Davies, P. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01879.x · Cited by 722
Ramsden, M., Kotilinek, L., Forster, C., Paulson, J., McGowan, E., SantaCruz, K., Guimaraes, A., Yue, M., Lewis, J., Carlson, G., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3279-05.2005 · Cited by 702 · cited 1×
“…commonly used tau transgenic mouse models, including JNPL3 (Acker et al., 2013; Lewis et al., 2000), PS19 (Yoshiyama et al., 2007), and rTg4510 (Ramsden et al., 2005), which all express frontotemporal dementia-associated mutant tau. hTau mice present impaired neurogenesis as early as 2 months…”
BackgroundFriedman, B. A., Srinivasan, K., Ayalon, G., Meilandt, W. J., Lin, H., Huntley, M. A., Cao, Y., Lee, S.-H., Haddick, P. C. G., Ngu, H., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2017.12.066 · Cited by 662 · cited 1×
“This is in contrast to the more aggressive models of tau pathology mentioned above, which all present both significant microgliosis (Asai et al., 2014; Yoshiyama et al., 2007) and “disease-associated” gene expression (Bennett, Bryant, et al., 2018; Friedman et al., 2018; Wang et al., 2018).”
ResultRegulation of Tau Pathology by the Microglial Fractalkine Receptor
Bhaskar, K., Konerth, M., Kokiko-Cochran, O. N., Cardona, A., Ransohoff, R. M., & Lamb, B. T. (2010) · Neuron · doi:10.1016/j.neuron.2010.08.023 · Cited by 639 · cited 2×
“Previous studies have suggested a beneficial role of microglia in hTau mice, as deficiency in either of the microglia-specific genes Cx3cr1 or Trem2 exacerbates tau pathology (Bemiller et al., 2017; Bhaskar et al., 2010; Maphis et al., 2015).”
BackgroundBruttger, J., Karram, K., Wörtge, S., Regen, T., Marini, F., Hoppmann, N., Klein, M., Blank, T., Yona, S., Wolf, Y., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.06.012 · Cited by 634 · cited 3×
“Following depletion, microglia proliferate extensively to refill the niche in a matter of days (Bruttger et al., 2015).”
BackgroundMethodResultA new fate mapping system reveals context-dependent random or clonal expansion of microglia
Tay, T. L., Mai, D., Dautzenberg, J., Fernández-Klett, F., Lin, G., Sagar, Datta, M., Drougard, A., Stempfl, T., Ardura-Fabregat, A., et al. (2017) · Nature Neuroscience · doi:10.1038/nn.4547 · Cited by 597 · cited 1×
“Microglial proliferation is a well characterized response to neurodegeneration (Gomez-Nicola, Fransen, Suzzi, & Perry, 2013; Tay et al., 2017).”
BackgroundMaphis, N., Xu, G., Kokiko-Cochran, O. N., Jiang, S., Cardona, A., Ransohoff, R. M., Lamb, B. T., & Bhaskar, K. (2015) · Brain · doi:10.1093/brain/awv081 · Cited by 595 · cited 6×
“Previous studies have suggested a beneficial role of microglia in hTau mice, as deficiency in either of the microglia-specific genes Cx3cr1 or Trem2 exacerbates tau pathology (Bemiller et al., 2017; Bhaskar et al., 2010; Maphis et al., 2015).”
BackgroundInfluentialYanamandra, K., Kfoury, N., Jiang, H., Mahan, T. E., Ma, S., Maloney, S. E., Wozniak, D. F., Diamond, M. I., & Holtzman, D. M. (2013) · Neuron · doi:10.1016/j.neuron.2013.07.046 · Cited by 574 · cited 1×
“Passive immunization has shown promise in reducing tau deposits in several models of tau pathology (Boutajangout, Ingadottir, Davies, & Sigurdsson, 2011; Castillo-Carranza et al., 2014; Chai et al., 2011; Dai et al., 2018; Yanamandra et al., 2013).”
BackgroundA combination of ontogeny and CNS environment establishes microglial identity
Bennett, F. C., Bennett, M. L., Yaqoob, F., Mulinyawe, S. B., Grant, G. A., Hayden Gephart, M., Plowey, E. D., & Barres, B. A. (2018) · Neuron · doi:10.1016/j.neuron.2018.05.014 · Cited by 524
Cell-cycle reentry and cell death in transgenic mice expressing nonmutant human tau isoforms
Andorfer, C., Acker, C. M., Kress, Y., Hof, P. R., Duff, K., & Davies, P. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4637-04.2005 · Cited by 511 · cited 3×
“However, we did not detect any difference in soluble oligomers between depleted and nondepleted hTau mice (Figure 4e). hTau mice develop more severe pathology with age, leading to accumulation of neurofibrillary tangles by 15 months (Andorfer et al., 2003, 2005).”
BackgroundDagher, N. N., Najafi, A. R., Kayala, K. M. N., Elmore, M. R. P., White, T. E., Medeiros, R., West, B. L., & Green, K. N. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0366-9 · Cited by 505 · cited 1×
“Another study used aged 3xTg-AD mice, which develop both plaques and tangles, and also accomplished a 30% reduction of microglia for 3 months using PLX5562, but again did not observe changes in total or phosphorylated tau levels (Dagher et al., 2015).”
BackgroundIn vivo cortical spreading pattern of tau and amyloid in the Alzheimer disease spectrum
Cho, H., Choi, J. Y., Hwang, M. S., Kim, Y. J., Lee, H. M., Lee, H. S., Lee, J. H., Ryu, Y. H., Lee, M. S., & Lyoo, C. H. (2016) · Annals of Neurology · doi:10.1002/ana.24711 · Cited by 499
Cronk, J. C., Filiano, A. J., Louveau, A., Marin, I., Marsh, R., Ji, E., Goldman, D. H., Smirnov, I., Geraci, N., Acton, S., et al. (2018) · Journal of Experimental Medicine · doi:10.1084/jem.20180247 · Cited by 412
Regulation of Microglial Proliferation during Chronic Neurodegeneration
Gómez-Nicola, D., Fransen, N. L., Suzzi, S., & Perry, V. H. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.4440-12.2013 · Cited by 407
Mildner, A., Schlevogt, B., Kierdorf, K., Böttcher, C., Erny, D., Kummer, M. P., Quinn, M., Brück, W., Bechmann, I., Heneka, M. T., et al. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.6209-10.2011 · Cited by 351 · cited 1×
“…during nonpathological situations (Cronk et al., 2018; Lund, Pieber, Parsa, Han, et al., 2018) but is considered minimal during the mouse lifespan, even during AD and amyotrophic lateral sclerosis neurodegenerative states (Ajami, Bennett, Krieger, Tetzlaff, & Rossi, 2007; Mildner et al., 2011).”
BackgroundAge-Dependent Impairment of Cognitive and Synaptic Function in the htau Mouse Model of Tau Pathology
Polydoro, M., Acker, C. M., Duff, K., Castillo, P. E., & Davies, P. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.1065-09.2009 · Cited by 329
Boutajangout, A., Ingadottir, J., Davies, P., & Sigurdsson, E. M. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07337.x · Cited by 306
Bemiller, S. M., McCray, T. J., Allan, K., Formica, S. V., Xu, G., Wilson, G., Kokiko-Cochran, O. N., Crish, S. D., Lasagna-Reeves, C. A., Ransohoff, R. M., et al. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0216-6 · Cited by 299 · cited 1×
“Previous studies have suggested a beneficial role of microglia in hTau mice, as deficiency in either of the microglia-specific genes Cx3cr1 or Trem2 exacerbates tau pathology (Bemiller et al., 2017; Bhaskar et al., 2010; Maphis et al., 2015).”
The role of microglia in processing and spreading of bioactive tau seeds in Alzheimer’s disease
Hopp, S. C., Lin, Y., Oakley, D., Roe, A. D., DeVos, S. L., Hanlon, D., & Hyman, B. T. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1309-z · Cited by 286 · cited 2×
“, 2015), seeding of tau deposits (Asai et al., 2015; Hopp et al., 2018) or tau-induced microglial death (Sanchez-”
BackgroundMicroglial activation correlates in vivo with both tau and amyloid in Alzheimer’s disease
Dani, M., Wood, M., Mizoguchi, R., Fan, Z., Walker, Z., Morgan, R., Hinz, R., Biju, M., Kuruvilla, T., Brooks, D. J., et al. (2018) · Brain · doi:10.1093/brain/awy188 · Cited by 270 · cited 1×
“Furthermore, in both mild cognitive impairment and AD subjects, microglial activation correlates with tau deposition as measured by PET imaging (Dani et al., 2018).”
BackgroundLund, H., Pieber, M., Parsa, R., Han, J., Grommisch, D., Ewing, E., Kular, L., Needhamsen, M., Espinosa, A., Nilsson, E., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07295-7 · Cited by 249 · cited 1×
“…control microglia displayed a similar low expression of genes associated with a neurodegenerative (Keren-Shaul et al., 2017; Krasemann et al., 2017; Lund et al., 2018) or a peripherally-derived state (Lund, Pieber, Parsa, Han, et al., 2018), including Ms4a7, Apoe, Siglec1, Clec12a, Mmp13, and Msr1…”
BackgroundSelf-citationLuo, W., Liu, W., Hu, X., Hanna, M., Caravaca, A., & Paul, S. M. (2015) · Scientific Reports · doi:10.1038/srep11161 · Cited by 241 · cited 3×
“In contrast, microglia have also been demonstrated to phagocytose and degrade tau deposits (Bolós et al., 2016; Luo et al., 2015; Majerova et al., 2014), indicating both protective and detrimental responses to tau aggregates.”
BackgroundDirect Evidence of Internalization of Tau by Microglia In Vitro and In Vivo
Bolós, M., Llorens-Martín, M., Jurado-Arjona, J., Hernández, F., Rábano, A., & Avila, J. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-150704 · Cited by 234
Soluble phospho-tau from Alzheimer’s disease hippocampus drives microglial degeneration
Sanchez-Mejias, E., Navarro, V., Jimenez, S., Sanchez-Mico, M., Sanchez-Varo, R., Nuñez-Diaz, C., Trujillo-Estrada, L., Davila, J. C., Vizuete, M., Gutierrez, A., et al. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1630-5 · Cited by 175 · cited 3×
“Recently, we and others have demonstrated that as a consequence of substantial microglial loss, peripherally-derived macrophages can take residence in the CNS parenchyma and become longlived microglia-like cells (Cronk et al., 2018; Lund, Pieber, Parsa, Han, et al., 2018; Shemer et al., 2018).”
BackgroundTau Oligomers: The Toxic Player at Synapses in Alzheimer’s Disease
Guerrero-Muñoz, M. J., Gerson, J., & Castillo-Carranza, D. L. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00464 · Cited by 168
Dai, C.-L., Hu, W., Tung, Y. C., Liu, F., Gong, C.-X., & Iqbal, K. (2018) · Alzheimer's Research & Therapy · doi:10.1186/s13195-018-0341-7 · Cited by 99
Partial reduction of microglia does not affect tau pathology in aged mice
Bennett, R. E., Bryant, A., Hu, M., Robbins, A. B., Hopp, S. C., & Hyman, B. T. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1348-5 · Cited by 91
Microglia display modest phagocytic capacity for extracellular tau oligomers
Majerova, P., Zilkova, M., Kazmerova, Z., Kovac, A., Paholikova, K., Kovacech, B., Zilka, N., & Novak, M. (2014) · Journal of Neuroinflammation · doi:10.1186/s12974-014-0161-z · Cited by 90 · cited 1×
“In contrast, microglia have also been demonstrated to phagocytose and degrade tau deposits (Bolós et al., 2016; Luo et al., 2015; Majerova et al., 2014), indicating both protective and detrimental responses to tau aggregates.”
BackgroundWang, H., Li, Y., Ryder, J. W., Hole, J. T., Ebert, P. J., Airey, D. C., Qian, H.-R., Logsdon, B., Fisher, A., Ahmed, Z., et al. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0296-y · Cited by 83 · cited 1×
“This is in contrast to the more aggressive models of tau pathology mentioned above, which all present both significant microgliosis (Asai et al., 2014; Yoshiyama et al., 2007) and “disease-associated” gene expression (Bennett, Bryant, et al., 2018; Friedman et al., 2018; Wang et al., 2018).”
Result
Cited by
Clayton, K., Delpech, J. C., Herron, S., Iwahara, N., Ericsson, M., Saito, T., Saido, T. C., Ikezu, S., & Ikezu, T. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00440-9 · Cited by 245
Mithaiwala, M. N., Santana-Coelho, D., Porter, G. A., & O’Connor, J. C. (2021) · Cells · doi:10.3390/cells10061548 · Cited by 190
Han, J., Sarlus, H., Wszolek, Z. K., Karrenbauer, V. D., & Harris, R. A. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01093-3 · Cited by 65
Self-citationMcFarland, K. N., & Chakrabarty, P. (2022) · Neurotherapeutics · doi:10.1007/s13311-021-01179-3 · Cited by 48
“In both instances, they did not observe any changes in tau levels [84].”
BackgroundResultA novel molecular class that recruits HDAC/MECP2 complexes to PU.1 motifs reduces neuroinflammation
Ralvenius, W. T., Mungenast, A. E., Woolf, H., Huston, M. M., Gillingham, T. Z., Godin, S. K., Penney, J., Cam, H. P., Gao, F., Fernandez, C. G., et al. (2023) · Journal of Experimental Medicine · doi:10.1084/jem.20222105 · Cited by 29
“Other studies using genetic ablation of microglia have found only modest effects and trends toward tau reduction (Zhu et al., 2020) or even an exacerbation of tau spread upon microglial depletion and intracerebral tau injection (Gratuze et al., 2021).”
Metadata
- Authors
- Zhu, K., Pieber, M., Han, J., Blomgren, K., Zhang, X., Harris, R. A., & Lund, H.
- Venue
- Glia
- Publisher
- Wiley
- Published
- 2020-02-10
- Volume
- 68
- Issue
- 7
- Pages
- 1466-1478
- ISSN
- 0894-1491 (ISSN-L)
- 1098-1136
- OpenAlex
- W3006311963
- Cited by
- 15
- References
- 39
- FWCI
- 1.51
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.